Clinical Trial Update: Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial assessing exenatide SR for prevention of prediabetes after kidney transplantation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation Related Diabetes Risk
• Pre-diabetes

Drugs mentioned

• Exenatide SR (exenatide)

Snippet

Sponsor: Mayo Clinic | Conditions: Pre Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2022-10-28